Teleconsultation for left ventricular assist device patients: a new standard of care

نویسندگان
چکیده

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Design an Equivalent Left Ventricular Assist Device for Medical Equipment Labs

LVAD is a mechanical pump supporting a weak heart function and blood flow. Sometimes, the heart may not recover fast enough to take over the pumping action immediately after surgery, in such patients a temporary support device has been employed to maintain the pumping action until the patient’s own heart recovers. This device can be considered as a temporary alternative before the process of ar...

متن کامل

Improvement of Left Ventricular Assist Device (LVAD) in Artificial Heart Using Particle Swarm Optimization

In this approach, the Left ventricular assist pump for patients with left ventricular failure isused. The failure of the left ventricle is the most common heart disease during these days. Inthis article, a State feedback controller method is used to optimize the efficiency of a samplingpump current. Particle Swarm Algorithm, which is a set of rules to update the position andvelocity, is applied...

متن کامل

Left ventricular-assist device arrest: total thrombosis of a continuous flow left ventricular-assist device.

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . doi:10.1093/ehjci/jev290 Online publish-ahead-of-pr...

متن کامل

New Treatments for Left Ventricular Assist Device-Associated Bleeding?

I n 2004, our program in Hannover, Germany, was among the first centers in the world gaining clinical experience with a new ventricular assist device (VAD) called the HeartMate II (HMII) (Thoratec Corporation, Pleasanton, California). At that time, hopes were not high because the pilot trial was designed to cover a 180-day bridge-to-transplant approach. There were concerns about pump thrombosis...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: European Journal of Heart Failure

سال: 2017

ISSN: 1388-9842

DOI: 10.1002/ejhf.943